Alternate treatments in asthma

Chest. 2003 Apr;123(4):1254-65. doi: 10.1378/chest.123.4.1254.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Asthmatic Agents / pharmacology*
  • Anti-Asthmatic Agents / therapeutic use*
  • Anticoagulants / pharmacology
  • Anticoagulants / therapeutic use
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Diuretics / pharmacology
  • Diuretics / therapeutic use
  • Folic Acid Antagonists / adverse effects
  • Folic Acid Antagonists / pharmacology
  • Folic Acid Antagonists / therapeutic use
  • Furosemide / pharmacology
  • Furosemide / therapeutic use
  • Gold / adverse effects
  • Gold / therapeutic use
  • Heparin / adverse effects
  • Heparin / pharmacology
  • Heparin / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / adverse effects
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use
  • Methotrexate / adverse effects
  • Methotrexate / pharmacology
  • Methotrexate / therapeutic use
  • T-Lymphocytes / drug effects
  • Troleandomycin / adverse effects
  • Troleandomycin / pharmacology
  • Troleandomycin / therapeutic use

Substances

  • Anti-Asthmatic Agents
  • Anticoagulants
  • Diuretics
  • Folic Acid Antagonists
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Gold
  • Furosemide
  • Cyclosporine
  • Heparin
  • Troleandomycin
  • Methotrexate